In a Phase 3 trial, Lilly found a weekly injection of retatrutide reduced moderate-to-severe obstructive sleep apnea severity ...

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...

Hims & Hers Health Inc. HIMS stock is trading lower on Tuesday in reaction to Amazon.com Inc. AMZN introducing a comprehensive GLP-1 Management Program through Amazon One Medical. The program aims to ...

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

The price of weight-loss drugs has been dropping in 2026. At the same time, employers have been cutting back on their coverage of the drugs.

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

Eli Lilly and its rivals, including Denmark's Novo Nordisk, are in a race to dominate the booming market for obesity and ...

Zepbound (tirzepatide) is a brand-name medication prescribed for weight loss and obstructive sleep apnea in certain adults. Zepbound works by slowing the passage of food through your stomach and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CVS Caremark, one of America’s most powerful pharmacy benefit managers, will begin covering more GLP-1 medications again ...